• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

氧疗对间质性肺病患者运动耐力和呼吸困难感知的急性影响。

Acute effect of oxygen therapy on exercise tolerance and dyspnea perception in ILD patients.

作者信息

Ora Josuel, Coppola Angelo, Perduno Andrea, Manzetti Gian Marco, Puxeddu Ermanno, Rogliani Paola

机构信息

Respiratory Medicine, Tor Vergata Hospital Foundation, Rome.

Respiratory Medicine, San Filippo Neri Hospital, Rome.

出版信息

Monaldi Arch Chest Dis. 2021 Oct 11;92(2). doi: 10.4081/monaldi.2021.1925.

DOI:10.4081/monaldi.2021.1925
PMID:34634897
Abstract

Ambulatory oxygen therapy (AOT) is commonly prescribed in interstitial lung disease (ILD) patients, with the aim of reducing dyspnea and increasing exercise tolerance. Despite its frequent use and a reasonable physiological rationale, there is a lack of evidence supporting the effect of AOT on improving dyspnea during exercise. Moreover, dyspnea encompasses distinct sensory (intensity, quality) and affective (anxiety, fear) components with different underlying neurophysiological mechanisms. The aim of this study was to evaluate the effect of oxygen supplementation on exercise tolerance and dyspnea in ILD patients with exercise induced hypoxia (EIH). Forty-seven ILD patients performed a six-minute walk test (6MWT) on room air (RA) and with oxygen supplementation (Ox). The 6MWT distance (6MWD) was significantly greater with oxygen supplementation (RA: 242±143 m vs Ox: 345±106 m p<0,01). With oxygen supplementation, the overall dyspnea and anxiety significantly decreased both at rest [1.1±1.4 Borg Unit (BU)] vs 0.4±0.9BU, p.<0.01, and 1.1±1.6BU vs 0.5±1.3 BU, p.<0.05, respectively) and at the end of exercise (5.1±2.6 BU vs 3.7±2.5 BU, p<0.001 and 3.4 ±2.9 vs 2.5±2.8, p.<0.01, respectively) despite a greater walked distance. In ILD patients with EIH, oxygen supplementation increases the exercise tolerance and reduces overall dyspnea perception and the anxiety component of breathlessness.

摘要

门诊氧疗(AOT)常用于间质性肺病(ILD)患者,目的是减轻呼吸困难并提高运动耐力。尽管其使用频繁且有合理的生理依据,但缺乏证据支持AOT对改善运动时呼吸困难的效果。此外,呼吸困难包括不同的感觉(强度、性质)和情感(焦虑、恐惧)成分,其潜在的神经生理机制不同。本研究的目的是评估补充氧气对运动性低氧(EIH)的ILD患者运动耐力和呼吸困难的影响。47例ILD患者在常氧(RA)和补充氧气(Ox)的情况下进行了6分钟步行试验(6MWT)。补充氧气时6MWT距离(6MWD)显著更长(RA:242±143米 vs Ox:345±106米,p<0.01)。补充氧气时,静息时总体呼吸困难和焦虑均显著降低[分别为1.1±1.4 Borg单位(BU) vs 0.4±0.9BU,p<0.01,以及1.1±1.6BU vs 0.5±1.3 BU,p<0.05],运动结束时也显著降低(分别为5.1±2.6 BU vs 3.7±2.5 BU,p<0.001以及3.4±2.9 vs 2.5±2.8,p<0.01),尽管步行距离更长。在患有EIH的ILD患者中,补充氧气可提高运动耐力并降低总体呼吸困难感知以及呼吸急促的焦虑成分。

相似文献

1
Acute effect of oxygen therapy on exercise tolerance and dyspnea perception in ILD patients.氧疗对间质性肺病患者运动耐力和呼吸困难感知的急性影响。
Monaldi Arch Chest Dis. 2021 Oct 11;92(2). doi: 10.4081/monaldi.2021.1925.
2
The impact of carrying supplemental oxygen on exercise capacity and dyspnea in patients with interstitial lung disease.携带补充氧气对间质性肺疾病患者运动能力和呼吸困难的影响。
Respir Med. 2018 May;138:32-37. doi: 10.1016/j.rmed.2018.03.025. Epub 2018 Mar 26.
3
[Acute effects of oxygen on dyspnea and exercise tolerance in patients with pulmonary emphysema with only mild exercise-induced oxyhemoglobin desaturation].[氧气对仅伴有轻度运动性氧合血红蛋白饱和度降低的肺气肿患者呼吸困难和运动耐力的急性影响]
Nihon Kokyuki Gakkai Zasshi. 2000 Nov;38(11):831-5.
4
The effect of domiciliary high flow nasal cannula treatment on dyspnea and walking distance in patients with interstitial lung disease - A pilot study.家庭高流量鼻导管治疗对间质性肺疾病患者呼吸困难和行走距离的影响 - 一项初步研究。
Chron Respir Dis. 2022 Jan-Dec;19:14799731221137085. doi: 10.1177/14799731221137085.
5
Supplemental oxygen for the management of dyspnea in interstitial lung disease.补充氧气治疗间质性肺疾病呼吸困难。
Curr Opin Support Palliat Care. 2019 Sep;13(3):174-178. doi: 10.1097/SPC.0000000000000434.
6
The effect of heated humidified nasal high flow oxygen supply on exercise tolerance in patients with interstitial lung disease: A pilot study.加温湿化经鼻高流量给氧对间质性肺疾病患者运动耐力的影响:一项初步研究。
Respir Med. 2021 Sep;186:106523. doi: 10.1016/j.rmed.2021.106523. Epub 2021 Jun 29.
7
Limitations to the 6-minute walk test in interstitial lung disease and pulmonary hypertension in scleroderma.硬皮病中间质性肺疾病和肺动脉高压患者6分钟步行试验的局限性
J Rheumatol. 2009 Feb;36(2):330-6. doi: 10.3899/jrheum.080447. Epub 2009 Jan 22.
8
A randomized cross-over trial on the direct effects of oxygen supplementation therapy using different devices on cycle endurance in hypoxemic patients with Interstitial Lung Disease.一项关于使用不同设备的氧补充治疗对低氧血症间质性肺疾病患者的循环耐力的直接影响的随机交叉试验。
PLoS One. 2018 Dec 28;13(12):e0209069. doi: 10.1371/journal.pone.0209069. eCollection 2018.
9
CT and physiologic determinants of dyspnea and exercise capacity during the six-minute walk test in mild COPD.CT 和生理因素决定了轻度 COPD 患者在六分钟步行试验中呼吸困难和运动能力。
Respir Med. 2013 Apr;107(4):570-9. doi: 10.1016/j.rmed.2012.12.011. Epub 2013 Jan 9.
10
Effects of walking with a portable oxygen concentrator on muscle oxygenation while performing normal or pursed-lip breathing in patients with interstitial lung disease: a randomized crossover trial.便携式氧气浓缩器对间质性肺疾病患者进行正常呼吸或缩唇呼吸时肌肉氧合的影响:一项随机交叉试验。
Ther Adv Respir Dis. 2023 Jan-Dec;17:17534666231186732. doi: 10.1177/17534666231186732.

引用本文的文献

1
Predicting New-onset Exertional and Resting Hypoxemia in Fibrotic Interstitial Lung Disease.预测纤维化间质性肺疾病新发运动性和静息性低氧血症。
Ann Am Thorac Soc. 2023 Dec;20(12):1726-1734. doi: 10.1513/AnnalsATS.202303-208OC.
2
Systemic complications of rheumatoid arthritis: Focus on pathogenesis and treatment.类风湿关节炎的全身并发症:关注发病机制和治疗。
Front Immunol. 2022 Dec 22;13:1051082. doi: 10.3389/fimmu.2022.1051082. eCollection 2022.
3
Physical activity pattern of patients with interstitial lung disease compared to patients with COPD: A propensity-matched study.
与 COPD 患者相比,间质性肺疾病患者的体力活动模式:一项倾向评分匹配研究。
PLoS One. 2022 Nov 21;17(11):e0277973. doi: 10.1371/journal.pone.0277973. eCollection 2022.
4
Oxygen Therapy during Exercise in Patients with Interstitial Lung Diseases.运动中特发性肺纤维化患者的氧疗。
Biomolecules. 2022 May 18;12(5):717. doi: 10.3390/biom12050717.